[Beta-interferon clinical trials using MRI in patients with multiple sclerosis].

Area of Science:

• Neurology
• Radiology
• Medical Imaging

Context:

• Multiple sclerosis (MS) management has been transformed by magnetic resonance imaging (MRI).
• MRI visualizes dynamic disease processes, enhancing diagnostic accuracy and lesion load assessment.
• It serves as a crucial secondary tool alongside clinical evaluation in MS patient monitoring.

Purpose:

• To review correlations between radiological and clinical findings in multiple sclerosis.
• To analyze the methodology of clinical trials investigating beta interferons for MS.
• To assess MRI's role in different MS subtypes: remitting, secondary progressive, and early onset.

Summary:

• Magnetic resonance imaging (MRI) provides critical data on the dynamic nature of multiple sclerosis (MS).
• The review synthesizes information on the relationship between MRI findings and clinical assessments.
• Methodologies of phase II and III trials using beta interferons for MS were examined.

Impact:

• Optimized diagnostic capabilities for multiple sclerosis.
• Formalized understanding of lesion load progression in MS patients.
• Informed clinical trial design and interpretation for MS therapeutics.